BRIEF published on 06/11/2026 at 07:05, 12 days 13 hours ago Biosynex finalizes the sale of its molecular biology business Restructuring Transfer BIOSYNEX Molecular Biology Rapid Diagnosis
BRIEF published on 06/11/2026 at 07:05, 12 days 13 hours ago Biosynex finalise la cession de son activité de biologie moléculaire Cession Restructuration BIOSYNEX Biologie Moléculaire Diagnostic Rapide
BRIEF published on 06/11/2026 at 07:05, 12 days 13 hours ago Biosynex cède son activité de biologie moléculaire Cession Croissance Stratégique BIOSYNEX Biologie Moléculaire Diagnostic Rapide
BRIEF published on 06/11/2026 at 07:05, 12 days 13 hours ago Biosynex sells its molecular biology business Strategic Growth Transfer BIOSYNEX Molecular Biology Rapid Diagnosis
PRESS RELEASE published on 06/11/2026 at 07:00, 12 days 13 hours ago BIOSYNEX SA: BIOSYNEX ANNONCE LA REALISATION DEFINITIVE DE LA CESSION DE SON ACTIVITE DE BIOLOGIE MOLECULAIRE Biosynex finalise la cession de son activité de biologie moléculaire avec levée des conditions suspensives. Larry Abensur commente le recentrage stratégique Stratégie Cession BIOSYNEX Biologie Moléculaire Larry Abensur
PRESS RELEASE published on 06/11/2026 at 07:00, 12 days 13 hours ago BIOSYNEX SA: BIOSYNEX ANNONCE LA REALISATION DEFINITIVE DE LA CESSION DE SON ACTIVITE DE BIOLOGIE MOLECULAIRE Biosynex annonce la réalisation de la cession de son activité de biologie moléculaire. Larry Abensur commente sur la stratégie future de la société Stratégie Cession BIOSYNEX Biologie Moléculaire Larry Abensur
BRIEF published on 05/25/2026 at 08:05, 29 days 12 hours ago BIOSYNEX Envisage la Cession de son Activité de Biologie Moléculaire Stratégie Cession Industrie Pharmaceutique BIOSYNEX Biologie Moléculaire
BRIEF published on 05/25/2026 at 08:05, 29 days 12 hours ago BIOSYNEX is considering the sale of its Molecular Biology business Pharmaceutical Industry Strategy Transfer BIOSYNEX Molecular Biology
BRIEF published on 05/25/2026 at 08:05, 29 days 12 hours ago Biosynex cède son activité de biologie moléculaire Cession BIOSYNEX Conditions Suspensives Biologie Moléculaire Industriel Pharmaceutique
BRIEF published on 05/25/2026 at 08:05, 29 days 12 hours ago Biosynex sells its molecular biology business Transfer BIOSYNEX Molecular Biology Conditions Precedent Pharmaceutical Manufacturer
Published on 06/23/2026 at 19:15, 58 minutes ago Fox River Obtains Securityholder Approval for Plan of Arrangement with Avenir Minerals Limited
Published on 06/23/2026 at 16:10, 4 hours 3 minutes ago Datavault AI Inc. (NASDAQ: DVLT) and WiSA Technologies Announce the Goho LS7 2.0 and 5.1 Home Theater Systems with WiSA E Wireless Connectivity
Published on 06/23/2026 at 16:00, 4 hours 13 minutes ago Secure Blockchain Appoints Former Polygon Executive Steven Bryson-Haynes as CEO to Drive Enterprise AI Commercialization
Published on 06/23/2026 at 15:45, 4 hours 28 minutes ago Amdocs Advances aOS Network Workflows with Live, Multivendor AI-RAN Solution and Industry Blueprint
Published on 06/23/2026 at 15:30, 4 hours 43 minutes ago Silver Spruce Resources, Inc. Adds Mine Production Knowledge to the Board
Published on 06/23/2026 at 18:30, 1 hour 43 minutes ago IEVA GROUP: COMPTE RENDU DE L’ASSEMBLÉE GÉNÉRALE ORDINAIRE ANNUELLE DU 23 JUIN 2026
Published on 06/23/2026 at 17:55, 2 hours 17 minutes ago ABO Energy ABO Energy drives strategic development and future financing solution forward
Published on 06/23/2026 at 17:53, 2 hours 19 minutes ago LIGHTON: LightOn confirms the total amount of its bond financing
Published on 06/23/2026 at 17:53, 2 hours 19 minutes ago LIGHTON: LightOn confirme le montant total de son financement obligataire
Published on 06/23/2026 at 19:47, 25 minutes ago GROUPE SFPI: reorganisation de la Direction Générale
Published on 06/23/2026 at 19:10, 1 hour 2 minutes ago GUILLEMOT CORPORATION > EVOLUTION DE LA GOUVERNANCE A COMPTER DU 23 JUIN 2026
Published on 06/23/2026 at 19:10, 1 hour 2 minutes ago GUILLEMOT CORPORATION: Changes to Corporate Governance Effective June 23, 2026
Published on 06/23/2026 at 18:32, 1 hour 40 minutes ago Communiqué sur la demande de radiation auprès d'Euroclear des Droits à Complément de Prix
